PORTO-
FREI

Cannabinoids as Therapeutics

In recent years, cannabis research has concentrated on the potential of cannabinoids as therapeutic substances, particularly in serious chronic illnesses such as multiple sclerosis. Most volumes published on cannabinoids so far concentrate on the biological activity, biochemistry and pharmacology, whereas this volume concentrates on the diseases, the physiological effects and therapeutic use of cannabinoids. The volume editor Prof. Mechoulam was the first who isolated the prime active constituent (THC, Tetrahydrocannabiol) of marijuana. He published extensively on the pharmacological activities of cannabinoids. The volume is of interest to researchers and clinicians from pharmacology, neuroscience, and medicinal research.

Buch (Gebunden)

EUR 267,49

Alle Preisangaben inkl. MwSt.

Auch verfügbar als:

  Verlagsbedingte Lieferzeit ca. 3 - 6 Werktage.
(Print on Demand. Lieferbar innerhalb von 3 bis 6 Tagen)

Versandkostenfrei*

Dieser Artikel kann nicht bestellt werden.
 

Produktbeschreibung

In recent years, cannabis research has concentrated on the potential of cannabinoids as therapeutic substances, particularly in serious chronic illnesses such as multiple sclerosis. Most volumes published on cannabinoids so far concentrate on the biological activity, biochemistry and pharmacology, whereas this volume concentrates on the diseases, the physiological effects and therapeutic use of cannabinoids. The volume editor Prof. Mechoulam was the first who isolated the prime active constituent (THC, Tetrahydrocannabiol) of marijuana. He published extensively on the pharmacological activities of cannabinoids. The volume is of interest to researchers and clinicians from pharmacology, neuroscience, and medicinal research. 

Inhaltsverzeichnis

Cannabis in India: ancient lore and modern medicine.- Cannabinoid chemistry: an overview.- Cannabidiol as a potential medicine.- Endocannabinoids and regulation of fertility.- Cannabinoids in neurodegeneration and neuroprotection.- Role of the endocannabinoid system in learning and memory.- Cannabinoids and anxiety.- Cannabinoid targets for pain therapeutics.- Potential use of cannabimimetics in the treatment of cancer.- Cannabinoids: effects on vomiting and nausea in animal models.- The skeleton: stone bones and stoned heads?.- Cannabinoids and drugs of abuse.- Cannabinoids in appetite and obesity.- The development of Sativex© - a natural cannabis-based medicine. 

Mehr vom Verlag:

k.A.

Mehr aus der Reihe:

Produktdetails

Medium: Buch
Format: Gebunden
Seiten: 284
Sprache: Englisch
Erschienen: Mai 2005
Auflage: 2005
Sonstiges: 978-3-7643-7055-8
Maße: 250 x 175 mm
Gewicht: 676 g
ISBN-10: 3764370556
ISBN-13: 9783764370558
Verlagsbestell-Nr.: 10975978

Bestell-Nr.: 819908 
Libri-Verkaufsrang (LVR):
Libri-Relevanz: 0 (max 9.999)
Bestell-Nr. Verlag: 10975978

Ist ein Paket? 0
Rohertrag: 57,50 €
Porto: 2,75 €
Deckungsbeitrag: 54,75 €

LIBRI: 7785062
LIBRI-EK*: 192.49 € (23%)
LIBRI-VK: 267,49 €
Libri-STOCK: 0
LIBRI: 097 Print on Demand. Lieferbar innerhalb von 7 bis 10 Tagen * EK = ohne MwSt.

UVP: 2 
Warengruppe: 16990 

KNO: 13716146
KNO-EK*: 164.99 € (25%)
KNO-VK: 267,49 €
KNO-STOCK: 0
KNO-MS: 97

KNO-SAMMLUNG: Milestones in Drug Therapy
KNOABBVERMERK: 2005. x, 268 S. X, 268 p. 244 mm
KNOSONSTTEXT: 978-3-7643-7055-8
KNOMITARBEITER: Herausgegeben:Mechoulam, Raphael
Einband: Gebunden
Auflage: 2005
Sprache: Englisch
Beilage(n): HC runder Rücken kaschiert

Alle Preise inkl. MwSt. , innerhalb Deutschlands liefern wir immer versandkostenfrei . Informationen zum Versand ins Ausland .

Kostenloser Versand *

innerhalb eines Werktages

OHNE RISIKO

30 Tage Rückgaberecht

Käuferschutz

mit Geld-Zurück-Garantie